J Tamaoki, E Tagaya, I Yamawaki, N Sakai, A Nagai and K Konno
First Department of Medicine, Tokyo Women's Medical College, Japan.

To determine whether the macrolide antibiotic erythromycin prevents microvascular leakage produced by lipopolysaccharide (LPS), we studied tracheae and lungs of pathogen-free rats. Tracheal vascular permeability and neutrophil recruitment were assessed by the percent area occupied by Monastral blue-labeled blood vessels and by myeloperoxidase-containing granulocytes, respectively, in tracheal whole mounts. Pulmonary microvascular leakage was evaluated by lung wet- to-dry (W/D) weight ratio. Inhalation of Escherichia coli LPS (5 mg/kg) caused time-dependent increases in tracheal vascular permeability, neutrophil influx, and lung W/D ratio. These responses were inhibited by pretreatment with oral erythromycin, but not by ampicillin or cefaclor, in a dose-dependent manner: erythromycin at 10 mg/kg daily for 1 wk reduced the area density of Monastral blue-labeled vessels from 6.7 +/- 1.2 to 1.4 +/- 0.3% (p < 0.01), the number of neutrophils (from 365 +/- 51 to 149 +/- 30 cells/mm2, p < 0.01), and lung W/D weight ratio (from 6.76 +/- 0.30 to 5.39 +/- 0.21, p < 0.01). This inhibitory effect of erythromycin was abolished by depletion of circulating neutrophils with cyclophosphamide. These results suggest that LPS causes acute lung injury, microvascular leakage, and neutrophil recruitment in the trachea, and that erythromycin protects against these changes, probably by acting on neutrophils.

This article has been cited by other articles:

				J. G. Laffey, D. Honan, N. Hopkins, J.-M. Hyvelin, J. F. Boylan, and P. McLoughlin Hypercapnic Acidosis Attenuates Endotoxin-induced Acute Lung Injury Am. J. Respir. Crit. Care Med., January 1, 2004; 169(1): 46 - 56. [Abstract] [Full Text] [PDF]

				Y. Gushima, K. Ichikado, M. Suga, T. Okamoto, K. Iyonaga, K. Sato, H. Miyakawa, and M. Ando Expression of matrix metalloproteinases in pigs with hyperoxia-induced acute lung injury Eur. Respir. J., November 1, 2001; 18(5): 827 - 837. [Abstract] [Full Text] [PDF]

				S. Abe, H. Nakamura, S. Inoue, H. Takeda, H. Saito, S. Kato, N. Mukaida, K. Matsushima, and H. Tomoike Interleukin-8 Gene Repression by Clarithromycin Is Mediated by the Activator Protein-1 Binding Site in Human Bronchial Epithelial Cells Am. J. Respir. Cell Mol. Biol., January 1, 2000; 22(1): 51 - 60. [Abstract] [Full Text]

				Y. Aoki and P. N. Kao Erythromycin Inhibits Transcriptional Activation of NF-kappa B, but not NFAT, through Calcineurin-Independent Signaling in T Cells Antimicrob. Agents Chemother., November 1, 1999; 43(11): 2678 - 2684. [Abstract] [Full Text]

				A. Azuma, T. Furuta, T. Enomoto, Y. Hashimoto, K. Uematsu, N. Nukariya, A. Murata, and S. Kudoh Preventive effect of erythromycin on experimental bleomycin-induced acute lung injury in rats Thorax, March 1, 1998; 53(3): 186 - 189. [Abstract] [Full Text]